Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways.

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase frequently upregulated in various cancers.
• EGFR aberrations, including mutations and truncations, lead to overactivation of pro-oncogenic signaling pathways.

Purpose of the Study:

• To review the molecular mechanisms regulating EGFR signal transduction.
• To focus on EGFR's role in G1 cell cycle progression and its downstream effectors.
• To discuss EGFR-targeted therapies and their combination with CDK4/6 inhibitors.

Main Methods:

• Review of molecular mechanisms of EGFR signal transduction.
• Analysis of EGFR structure, mutations, ligand binding, and dimerization.
• Examination of signaling pathways leading to cell cycle progression.

Main Results:

• EGFR signaling pathways activate pro-oncogenic pathways like MAPK and PI3K/AKT.
• EGFR signaling induces CYCLIN D expression, CDK4/6 activation, and represses CDKi.
• These events promote cancer cell proliferation and cell cycle progression.

Conclusions:

• EGFR aberrations are key drivers of cancer cell proliferation through cell cycle regulation.
• EGFR-targeted therapies show promise but face challenges.
• Combination therapy with CDK4/6 inhibitors holds potential for improved cancer treatment.